Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Beta Bionics, Inc. - Common Stock (NQ:BBNX)

20.82 -1.36 (-6.11%)

Streaming Delayed Price Updated: 11:22 AM EDT, Sep 17, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,213,048
Open	22.46
Bid (Size)	20.80 (300)
Ask (Size)	20.85 (500)
Prev. Close	22.18
Today's Range	20.80 - 22.66
52wk Range	8.800 - 32.71
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Kaplan Fox Continues to Alert Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to a Class Action Deadline on November 3, 2026

Today 9:45 EDT

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Beta Bionics, Inc. (BBNX)

Today 8:24 EDT

From Bernstein Liebhard LLP

Via GlobeNewswire

Performance

YTD	-28.8%	-28.8%
1 Month	+18.6%	+18.6%
3 Month	+57.9%	+57.9%
6 Month	+95.9%	+95.9%
1 Year	-10.6%	-10.6%

More News

Kaplan Fox Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors Seeking Recovery to Contact the Firm Before November 3, 2026

September 16, 2026

Via NewMediaWire

BETA BIONICS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Beta Bionics, Inc. and Encourages Investors to Contact the Firm

September 16, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Kaplan Fox Reminds Beta Bionics, Inc. (NASDAQ: BBNX) Investors Seeking Recovery of the Lead Plaintiff Deadline on November 3, 2026

September 16, 2026

From Kaplan Fox & Kilsheimer, LLP

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Beta Bionics, Inc. (NASDAQ: BBNX); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law Office is Investigating Claims on Your Behalf

September 16, 2026

From Grabar Law Office

Via GlobeNewswire

Beta Bionics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

September 15, 2026

From Beta Bionics, Inc.

Via GlobeNewswire

Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

September 15, 2026

From Kahn Swick & Foti, LLC

Via GlobeNewswire

Beta Bionics Announces Proposed Public Offering of $125.0 Million of Common Stock

September 15, 2026

From Beta Bionics, Inc.

Via GlobeNewswire

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBNX

September 15, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit

September 15, 2026

From Schall, Brown & Schwartz LLP

Via GlobeNewswire

BETA BIONICS, INC. INVESTORS WITH LOSSES HAVE UNTIL NOVEMBER 3, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

September 15, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

Did You Lose Money Investing in Beta Bionics, Inc.? Robbins LLP Urges Investors with Significant Losses to Contact the Firm for Information About Their Rights Against BBNX

September 14, 2026

Via Newsfile

Beta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as its Next-Generation Insulin Dosing Algorithm

September 14, 2026

From Beta Bionics, Inc.

Via GlobeNewswire

Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas

September 14, 2026

From Senseonics Holdings, Inc.

Via GlobeNewswire

Kaplan Fox Encourages Investors of Beta Bionics, Inc. (NASDAQ: BBNX) Who Suffered Losses to Contact the Firm Before November 3, 2026

September 11, 2026

From Kaplan Fox & Kilsheimer, LLP

Via GlobeNewswire

Deadline Approaching: Beta Bionics, Inc. (BBNX) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith

September 11, 2026

From Law Offices of Howard G. Smith

Via Business Wire

Kaplan Fox Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Contact the Firm Before the Lead Plaintiff Deadline on November 3, 2026

September 11, 2026

Via NewMediaWire

Levi & Korsinsky Reminds Beta Bionics, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 3, 2026 - BBNX

September 11, 2026

From Levi & Korsinsky, LLP

Via Business Wire

Kaplan Fox Encourages Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to Contact the Firm Before Lead Plaintiff Deadline on November 3, 2026

September 10, 2026

Via NewMediaWire

Deadline Soon: Beta Bionics, Inc. (BBNX) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

September 10, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

BETA BIONICS, INC. INVESTORS WITH LOSSES HAVE UNTIL NOVEMBER 3, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

September 10, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

Kaplan Fox Reminds Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to a Securities Class Action Deadline - Contact the Firm Before November 3, 2026

September 10, 2026

Via NewMediaWire

Kaplan Fox & Kilsheimer LLP Alerts Beta Bionics, Inc. (NASDAQ: BBNX) Investors to a Securities Class Action Deadline on November 3, 2026

September 09, 2026

From Kaplan Fox & Kilsheimer, LLP

Via GlobeNewswire

Kaplan Fox Encourages Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to Contact the Firm to Learn About Their Legal Rights

September 09, 2026

Via NewMediaWire

Frequently Asked Questions

Is Beta Bionics, Inc. - Common Stock publicly traded?

Yes, Beta Bionics, Inc. - Common Stock is publicly traded.

What exchange does Beta Bionics, Inc. - Common Stock trade on?

Beta Bionics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Beta Bionics, Inc. - Common Stock?

The ticker symbol for Beta Bionics, Inc. - Common Stock is BBNX on the Nasdaq Stock Market

What is the current price of Beta Bionics, Inc. - Common Stock?

The current price of Beta Bionics, Inc. - Common Stock is 20.82

When was Beta Bionics, Inc. - Common Stock last traded?

The last trade of Beta Bionics, Inc. - Common Stock was at 09/17/26 11:22 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.